Sanofi SNY (transcript via SeekingAlpha)
"You've seen the advisory committee, which voted in favor of KYNAMRO for Homozygous Familial Hypercholesterolemia just last week, PDUFA date in January and a European opinion in the fourth quarter of this year. "
Biogen BIIB - no comments about Isis partnerships